Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.

Allogeneic-HCT (allo-HCT), while potentially curative, can result in significant complications including graft versus host disease (GVHD). Prior studies suggest that metabolic syndrome may be one risk factor for GVHD. We hypothesized that hepatic steatosis on pre-HCT computed tomography (CT) scans may be a marker for development of GVHD and poor outcomes in allo-HCT. In this retrospective study, we reviewed the pre-HCT CT scans and transplant outcome data of patients who underwent allo-HCT at Duke University Medical Center from 2009 to 2017. The presence of steatosis was confirmed using CT attenuation measurements. We then assessed the association between pre-HCT hepatic steatosis and HCT-related outcomes including GVHD. 80 patients who had pre-HCT CT scans were included in the study. Pre-transplant hepatic steatosis was associated with the development of chronic GVHD (OR 4.2, p = 0.02), but was not associated with acute GVHD (OR 1.3, p = 0.7), non-relapse mortality (p = 0.81) or overall survival (p = 0.74). Based on this single center retrospective study, pre-transplant hepatic steatosis is associated with development of chronic GVHD. Further, prospective study with other imaging modalities including non-contrasted CT scans is needed to determine if this association is reproducible.

Duke Scholars

Author Sin-Ho Jung Biostatistics & Bioinformatics, Division of Integrative Geno ...

Author Nelson Jen An Chao Medicine, Hematologic Malignancies and Cellular Therapy

Author Taewoong Choi Medicine, Hematologic Malignancies and Cellular Therapy

Author Anna Mae Diehl Medicine, Gastroenterology

Author Louis Frederic Diehl Medicine, Hematologic Malignancies and Cellular Therapy

Author Cristina Gasparetto Medicine, Hematologic Malignancies and Cellular Therapy

Author Mitchell Eric Horwitz Medicine, Hematologic Malignancies and Cellular Therapy

Author Gwynn Douglas Long Medicine, Hematologic Malignancies and Cellular Therapy

Author Richard D Lopez Medicine, Hematologic Malignancies and Cellular Therapy

Author Stefanie Sarantopoulos Medicine, Hematologic Malignancies and Cellular Therapy

Author Keith Michael Sullivan Medicine, Hematologic Malignancies and Cellular Therapy

Author Mustafa Shadi Rifaat Bashir Radiology, Abdominal Imaging

Author Anthony D Sung Medicine, Hematologic Malignancies and Cellular Therapy